Última Hora: "Algarve: Ocupação subiu em agosto, dormidas de espanhóis foram as ... - RTP" Mon, 06 Sep 2010 14:55:11 GMT+00:00    "Preço do petróleo a descer - Correio da Manhã" Mon, 06 Sep 2010 13:03:49 GMT+00:00    "PT e EDP lideram ganhos na bolsa nacional - Jornal de Negócios - Portugal" Mon, 06 Sep 2010 10:18:43 GMT+00:00    "Bolsa de Tóquio sobe 2,1% beneficiada por payroll - Estadão" Mon, 06 Sep 2010 12:17:34 GMT+00:00    "Euribor: Taxas caem em todos os prazos - Correio da Manhã" Mon, 06 Sep 2010 12:16:49 GMT+00:00   "Governo assegura que TAP não será vendida na totalidade - Público.pt" Mon, 06 Sep 2010 13:30:35 GMT+00:00    "PSI 20 mantém ganhos da abertura com 15 cotadas em alta - DiarioEconomico.com" Mon, 06 Sep 2010 11:28:30 GMT+00:00    "British Airways e Iberia estudam 12 aquisições - Diário Económico" Mon, 06 Sep 2010 11:44:33 GMT+00:00    "Autoridade detecta 402 casos de despedimento ilegal - Diário de Notícias - Lisboa" Mon, 06 Sep 2010 12:39:43 GMT+00:00    "Açores: Carlos César admite eléctrica açoriana EDA - Diário Digital" Mon, 06 Sep 2010 14:15:01 GMT+00:00      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Queda de
-0,020 (-0.04%%) SANOFI-AVENTIS - [Ticker: SAN.PA]Gráfico SANOFI-AVENTIS  Notícias SANOFI-AVENTIS  Download de Históricos Metastock SANOFI-AVENTIS e Outros  Análise Técnica SANOFI-AVENTIS  
Última Trade46,780Range 52 Semanas[44,010 - 58,900]
Hora da Última Trade2010-09-06 - 15:58Price-Target 1 AnoN/A
Variação-0,020 (-0.04%)Capitalização Bolsista0
Bid / Ask46,780 x 1 - 189,000 x 47EPS0,00
Abertura47,060PERN/A
Máximo47,140Pagamento DividendoN/A
Mínimo46,705Data Ex-Dividendo2010-09-06
Fecho Anterior54,000Yield5,13
Volume977.010Volume Médio (3m)3.214.824
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de SANOFI-AVENTIS -  [Ticker: SAN.PA]
Mudar para Gráfico de Análise Técnica Interactiva de SANOFI-AVENTIS

Últimos 10 Tópicos no Fórum sobre SANOFI-AVENTIS:
Não foram encontrados tópicos sobre SANOFI-AVENTIS [SAN.PA], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SANOFI-AVENTIS.

 Notícias sobre SANOFI-AVENTIS [SAN.PA]:   (ordenadas por relevância)

Sanofi-Aventis may up Genzyme bid
Pharmacy Europe
Sanofi-aventis, the French pharmaceutical firm, has said it may improve its offer to buy out Genzyme if the US biotech company undertakes negotiations. ...
Stock of Local Interest: Sanofi-AventisScranton Times-Tribune
GENZYME CEO LOOKING FOR A HIGHER SANOFI-AVENTIS BID: REPORTTrading Markets (press release)
Sanofi ready to raise bid if Genzyme talks - reportReuters UK
CITY A.M. -MarketWatch -Reuters
all 30 news articles »

Sanofi Aventis (SNY) 9/7/10 PriceWatch Alert Support Down To $29.83
Market Intelligence Center
Sanofi Aventis (NYSE: SNY) ended the last trading session at $30.20. So far the stock has hit a 52-week low of $28.01 and 52-week high of $41.59. ...


Deloitte Recap Honors Sanofi-aventis And Exelixis with Prestigious BD Awards
Big4
Deloitte Recap awarded Sanofi-aventis and Exelixis, the prestigious Allicense 2010 Breakthrough Alliance Award ...


Reuters

Ahead of the Bell: Sanofi-Aventis
BusinessWeek
A Jefferies & Co. analyst reaffirmed on Monday a "Buy" rating on Sanofi-Aventis, citing the company's bid for Genzyme Corp. and positive study data on a ...
Sanofi-Aventis Makes $18.5B All-Cash Offer For GenzymeWall Street Journal
Sanofi-Aventis makes $18.5-billion cash offer for GenzymeLos Angeles Times
Asia Day Ahead: Sanofi-Aventis Offering $18.5 Billion in Cash for GenzymeBloomberg
MarketWatch -The Associated Press -Bizjournals.com
all 1,238 news articles »

Sanofi-Aventis, Donaldson, Winn-Dixie, 3Par, HP, Dell
MarketWatch
By MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Monday's session are Sanofi-Aventis, ...

and more »

Sanofi-Aventis's Multaq Gets Recommendation In ESC Guidelines
Wall Street Journal
PARIS (Dow Jones)--Sanofi Aventis (SNY) Sunday said that its Multaq drug was granted a class I recommendation in the European Society of Cardiology's new ...
European guidelines back use of Sanofi's MultaqReuters

all 25 news articles »

Telegraph.co.uk

Merger Twist - S&P Upgrades Sanofi Aventis (SNY) to Buy
Benzinga
Especially since most analysts think that Sanofi Aventis (NYSE: SNY) will raise its bid for Genzyme (NASDAQ: GENZ) But S&P raised Sanofi to Buy from Hold ...
Genzyme Rejects Sanofi-Aventis's Acquisition ProposalPharmaceutical Technology Magazine
Termeer speaks up on Genzyme sale priceFiercePharma
Analysis: Genzyme units attract interest, what about Sanofi?Reuters
Telegraph.co.uk -PRLog.Org (press release) -New York Times (blog)
all 51 news articles »

Sanofi-Aventis: RMS drug meets primary endpoint in phase-3 study
Drug Store News
Sanofi-Aventis said its once-daily oral drug teriflunomide, which was tested as a monotherapy, reduced annualized relapse rate at two years versus placebo ...
Sanofi-Aventis: relapsing-MS drug meets endpointMarketWatch
Sanofi-Aventis (SNY) Upgraded at Societe GeneraleComtex Smartrend
Sanofi-aventis Says Teriflunomide Significantly Reduced Annualized Relapse ...Stock Markets Review
Capital.gr (press release) -PR Newswire (press release) -Bloomberg
all 45 news articles »

Sanofi-Aventis - Best Performing Pharmaceutical
TradersHuddle.com
The sector's top performer today was Sanofi-Aventis (NYSE:SNY) closing the trading session at $30.2 representing 1.68%. versus the previous trading session ...

and more »

Moneycontrol.com

Both Sides Playing Hard To Get In Sanofi-Aventis And Genzyme Deal (SNY,GENZ ...
Comtex Smartrend
... sources told Bloomberg that Sanofi-Aventis (NYSE:SNY) was unlikely to go beyond its currently authorized $70, and it may look for other suitors. ...
Carrefour, Casino, Sanofi-Aventis, Total May Move: French Equity PreviewBloomberg
Sanofi-Aventis Not To Raise Genzyme BidEmii.com
Genzyme Seeks at Least $75 per Share From Sanofi-AventisPharmaLive (press release) (subscription)
Financial Times -Beacon Equity Research (blog) -Reuters
all 90 news articles »
Para mais notícias sobre SANOFI-AVENTIS clique aqui:
Notícias de SANOFI-AVENTIS
Pesquisas na Internet:

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2010 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters